期刊文献+

CD68在胃癌组织中表达的意义及对肿瘤复发的影响 被引量:7

Significance of CD68 expression in gastric cancer tissues and tumor recurrence
下载PDF
导出
摘要 目的探讨巨噬细胞在不同分期的胃癌组织中的浸润情况以及对胃癌术后复发率的影响。方法采用免疫组化染色法检测CD68在52例胃癌术后病人组织中的表达,比较不同分期的胃癌组织中CD68表达的差异,以及CD68对胃癌术后病人复发率的影响。结果 52例胃癌组织切片中均见CD68表达,巨噬细胞浸润的密度为23-154/HP;肿瘤相关巨噬细胞(tumor-associated macrophages,TAMs)在Ⅰ-Ⅱ期胃癌组织浸润的密度为41.02±8.47/HP,在Ⅲ期浸润的密度为74.10±13.49/HP,在Ⅳ期浸润的密度为126.10±13.35/HP,三者比较有明显差异(P<0.05)。高密度TAM浸润病人术后1年、2年、3年的累计复发率明显高于低密度的病人(P<0.05)。结论巨噬细胞在胃癌组织中的浸润随着胃癌分期增加而增加,高密度浸润的肿瘤相关巨噬细胞预后差且更容易出现术后的复发。 Objective To explore macrophage infiltration in different stages of gastric cancer tissue and its effect on gastric cancer recurrence rate.Methods Using immunohistochemical staining to detect CD68 in 52 cases of postoperative patients with gastric cancer tissues,and comparison of different stages of the differential expression of CD68 in gastric cancer tissues,and CD68 in patients with gastric cancer recurrence after effect.Results In 52 cases of gastric cancer tissue sections were seen in CD68 expression of macrophage infiltration,density is 23-154/HP.TAM in stage Ⅰ-Ⅱ infiltration density was 41.02±8.47/HP,in stage Ⅲ infiltration density was 74.10±13.49/HP,and in stage Ⅳ infiltration density was 126.10±13.35/HP.There is obvious difference between the three(P0.05).High density TAM infiltration cumulative recurrence patients after 1 years,2 years,3 years was significantly higher than that of the low density of the patients(P0.05).Conclusion Macrophage infiltration in gastric cancer tissues increases with the increase in gastric cancer staging,and the high density of tumor-associated macrophage infiltration and more prone to postoperative recurrence and poor prognosis.
出处 《中国实验诊断学》 2013年第6期1050-1052,共3页 Chinese Journal of Laboratory Diagnosis
关键词 胃癌 巨噬细胞 CD68 复发 gastric cancer macrophage CD68 recurrence
  • 相关文献

参考文献9

二级参考文献40

  • 1金晓明,李雅馨,刘桂芳,李金荣,李宁毅,贾暮云.血管内皮生长因子对口腔鳞状细胞癌细胞侵袭能力的影响[J].现代口腔医学杂志,2005,19(1):67-69. 被引量:5
  • 2宋宇峰,冯红超,温玉明.口腔鳞状细胞癌中巨噬细胞浸润和肿瘤生长、转移的关系[J].中华口腔医学杂志,2005,40(5):385-385. 被引量:9
  • 3彭娟,丁童,郑利民,邵建永.肿瘤相关巨噬细胞对鼻咽癌进展和预后的影响[J].癌症,2006,25(11):1340-1345. 被引量:17
  • 4孙乐刚,刘玲,冯红超,宋宇峰.血管细胞粘附分子-1在口腔鳞状细胞癌中的表达及其与血管生成的关系[J].现代口腔医学杂志,2007,21(3):267-270. 被引量:7
  • 5Van Ravenswaay Claasen HH, Kluin PM, Fleuren GJ. Tumor infiltrating cell in human cancer, on the possible role of CD16+ macrophage in antitumor cytotoxity [J]. Lab Invest, 1992,67(2) : 166-174.
  • 6Van Netten JP, George EJ, Ashmead BJ, et al. Macrophagetumour cell associations in breast cancer [J]. Lancet, 1993, 342(8875 ) : 872-873.
  • 7Takanami I, Takeuchi K, Kodaira S. Tumor-associated macrophage infiltration in pulmonary adenocarcinoma:association with angiogenesis and poor prognosis [J]. Oncology, 1999,57(2) : 138-142.
  • 8Lindsay TH, Jonas BM, Sevcik MA, et al. Pancreatic cancer pain and its correlation with changes in tumor vasculature, macrophage infiltration, neuronal innervation, body weight and disease progression [J ]. Pain, 2005,119(1-3) : 233-246.
  • 9Wang X, Deavers M, Patenia R, et al. Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease [J]. J Transl Med, 2006,4 (30): 1-11.
  • 10Melichar B, Savary CA, Patenia R. Phenotype and antitumor activity of ascitic fluid monocytes in patients with ovarian carcinoma [J]. Int J Gynecol Cancer, 2003,13(4) :435-443.

共引文献42

同被引文献81

  • 1盛世乐,黄钢.VEGF上调survivin和bcl-2表达及抑制乳腺癌细胞凋亡的机制探讨[J].肿瘤,2005,25(6):525-529. 被引量:17
  • 2Mielgo A, Schmid MC. Impact of tumour associated macrophages in pancreatic cancer[ J]. BMB Rep,2013,46(3 ) : 131-138.
  • 3Partecke LI, Gtinther C, Hagemann S, et al. Induction of M2-mac- rophages by tumour cells and tumour growth promotion by M2-mac- rophages: a quid pro quo in pancreatic cancer[ J]. Pancreatology, 2013,13(5) :508-516.
  • 4Yoshikawa K, Mitsunaga S, Kinoshita T, et al. Impact of tumor-as- sociated macrophages on invasive ductal carcinoma of the pancreas head[ J]. Cancer Sci ,2012,103 ( 11 ) :2012-2020.
  • 5Sideras K, Braat H, Kwekkeboom J, et al. Review : Role of the im- mune system in pancreatic cancer progression and immune modula- ting treatment strategies [ J ]. Cancer Treat Rev, 2014,40 ( 4 ) : 513-522.
  • 6Mitchem JB, Brennan D J, Knolhoff BL, et al. Targeting tumor-in- filtrating macrophages decreases tumor-initiating cells, relieves im- munosuppression, and improves chemotherapeutic responses [ J ]. Cancer Res,2013,73(3) :1128-1141.
  • 7Olson P, Chu GC, Perry SR, et al. Imaging guided trials of the angiogenesis inhibitor sunitinib in mouse models predict efficacy in pancreatic neuroendocrine but not ductal carcinoma[ J]. Proc Nati Acad Sci USA ,2011,108 (49) : 1275-1284.
  • 8Kurahara H, Takao S, Maemura K, et al. M2-polarized tumor-as- sociated macrophage infiltration of regional lymph nodes is associat- ed with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer[ J]. Pancreas ,2013,42 ( 1 ) :155-159.
  • 9Magdalena Krol, Joanna Mucha, Kinga Majchrzak, et al. Macro- phages Mediate a Switch between Canonical and Non-Canonical Wnt Pathways in Canine Mammary Tumors[ J]. PLoS One, 2014, 9 ( 1 ) : e83995.
  • 10Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer [ J ]. N Engl J Med, 2011,364(19) :1817-1825.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部